Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine
Crossref DOI link: https://doi.org/10.1038/s41598-023-48298-9
Published Online: 2023-11-28
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xie, Fang
Huang, Mei
Lin, Xiansheng
Liu, Chenhai
Liu, Zhen
Meng, Futao
Wang, Chao
Huang, Qiang
Text and Data Mining valid from 2023-11-28
Version of Record valid from 2023-11-28
Article History
First Online: 28 November 2023